Peregrine Market Access, a full-service consulting, communications, and commercialization partner for the life sciences industry, announced the hiring of Mawais Farooqui as a data analyst and Lewis “Lewi” Clarke as an associate account executive.
Tag Archive for: market access
Many pharmaceutical companies listed strategic objectives for 2024 that included solving for health inequities, clearly positioned within pillars that focused on improving or increasing the value of their products. For one reason or another, many of those objectives were set aside as planning commenced in the new year, leaving this crushing challenge to our society unaddressed.
Tristan Bernard was elevated to account director, Jennifer Peckins to VP, account services, and Catherine Lawyer to senior research analyst. Bernard supports Peregrine’s clients with achieving their brand objectives at all stages of a product’s lifecycle. Peckins oversees multiple managed care client accounts spanning various disease states, including dermatology, immunology, pulmonology, rare disease, and oncology. Lawyer uses her knowledge of quantitative and qualitative research, business intelligence, and analytics to gather data-based insights and provide strategic recommendations to help clients boost the competitiveness of their products.
Market access emerged as a crucial commercial function at pharmaceutical manufacturers a little over 20 years ago, followed closely by the creation of specialized market access agencies. With so much changing over the last two decades, the time is right to take a fresh look at how market access agencies support manufacturers today to ensure that expectations are aligned and that unrealized potential doesn’t negatively impact brands.
The agency has elevated employees to senior art directors and senior medical strategists.
Three general manager positions and one vice president position mark the latest career advancements at the fast-growing company.
In 2024, the industry must acknowledge the interconnected impact of the Inflation Reduction Act (IRA), growing AI and technology usage, and evolving smart data, as these factors create a ripple effect. How market access responds to these effects will impact sales and marketing. Effectively addressing these impacts lies at the heart of industry reform.
We at Med Ad News don’t claim to know all the questions. So we challenged our contributors to come up with their own questions and answer them.
In an interview with Med Ad News, Leo Tarkovsky, chief commercial officer at Fingerpaint Group discusses the transformation in what clients want and need with respect to their partners, along with the evolving expectations of healthcare companies.
As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors. There are the usual suspects like evolving provider models, the continued transition to value-based care, and pharma and biotech companies’ increased investment in “access,” but there are two trends that are at the top of the “what we’re watching” list for 2024.
